Investing
Investing Cash Flow
United Therapeutics Investing Cash Flow increased by 426.8% to $743.70M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 551.5%, from -$164.70M to $743.70M. Over 3 years (FY 2021 to FY 2025), Investing Cash Flow shows a downward trend with a 4.2% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026
How to read this metric
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
Detailed definition
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Peer comparison
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
Metric ID:
net_cash_from_investingHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$48.90M | -$235.90M | -$195.80M | -$359.20M | -$169.00M | -$94.00M | -$189.30M | -$221.10M | -$227.20M | -$313.40M | $0.00 | $735.30M | -$80.00M | -$114.90M | -$164.70M | -$299.90M | $140.90M | -$227.60M | $743.70M |
| QoQ Change | — | -382.4% | +17.0% | -83.5% | +53.0% | +44.4% | -101.4% | -16.8% | -2.8% | -37.9% | +100.0% | — | -110.9% | -43.6% | -43.3% | -82.1% | +147.0% | -261.5% | +426.8% |
| YoY Change | — | — | — | — | -245.6% | +60.2% | +3.3% | +38.4% | -34.4% | -233.4% | +100.0% | +432.6% | +64.8% | +63.3% | -122.4% | -274.9% | +222.6% | — | +551.5% |
Range-$359.20M – $743.70M
CAGR+83.1%
Avg YoY Growth+44.7%
Median YoY Growth+49.3%
Investing Cash Flow at Other Companies
Frequently Asked Questions
- What is United Therapeutics's investing cash flow?
- United Therapeutics (UTHR) reported investing cash flow of $743.70M in Q1 2026.
- How has United Therapeutics's investing cash flow changed year-over-year?
- United Therapeutics's investing cash flow increased by 551.5% year-over-year, from -$164.70M to $743.70M.
- What is the long-term trend for United Therapeutics's investing cash flow?
- Over 3 years (2021 to 2025), United Therapeutics's investing cash flow has grown at a 4.2% compound annual growth rate (CAGR), from -$486.90M to -$551.30M.
- What does investing cash flow mean?
- The net amount of cash spent on or received from investing activities.